50% off Premium Yearly

NASDAQ:HSIC
This summary was created by AI, based on 1 opinions in the last 12 months.
Henry Schein Inc. has shown impressive financial performance, particularly in its last quarter, indicating that the company is effectively capitalizing on its market opportunities. Many experts have recognized that the company generates substantial profits, which may contribute to investor confidence. This positive momentum reflects not only strong revenue growth but also a solid operational framework. With a keen focus on providing essential products and services, Henry Schein Inc. has positioned itself well within its industry, and analysts suggest that ongoing demand in the healthcare sector will continue to support its robust financial results.
Henry Schein Inc. is a American stock, trading under the symbol HSIC (previously HSIC-Q on Stockchase) on the NASDAQ (HSIC). It is usually referred to as NASDAQ:HSIC or HSIC
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on HSIC (previously HSIC-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Henry Schein Inc..
Henry Schein Inc. was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Henry Schein Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Henry Schein Inc..
Henry Schein Inc. is covered by Stockchase experts and is worth watching.
On 2026-08-31, Henry Schein Inc. (HSIC) stock closed at a price of $89.16.
They make a ton of money and their last quarter was goo.